SD
Sanket Dhondiraj Sawant
About Sanket Dhondiraj Sawant
Data last updated:
Sanket Dhondiraj Sawant is a Director at R.N. Laboratories Private Limited (since 2021), Director at Garonit Pharmaceuticals Private Limited (since 2024) and Designated Partner at Sanhit Risk & Growth Llp (since 2024). The companies operate in Pharma and Non-Profit Organizations. The 2 current companies with reported revenue have a combined latest revenue of ₹135 Cr; the largest is R.N. Laboratories Private Limited at ₹135 Cr (FY 2025). Earlier, Sanket Dhondiraj Sawant was an Additional Director at Neelam Garg Foundation (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 R.N. Laboratories Private Limited U24200MH1998PTC117339 | Director | 30 Jul 2021 | 1998 | ₹135 Cr (FY 2025) | Active |
 Garonit Pharmaceuticals Private Limited U24290MH2021FTC355132 | Director | 24 Dec 2024 | 2021 | ₹1.5 Lakh (FY 2025) | Active |
| Sanhit Risk & Growth Llp ACJ-4199 | Designated Partner | 10 Sep 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Neelam Garg Foundation U85300MH2021NPL361103 | Additional Director | 24 Dec 2024 | 2021 | ₹24.3 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanket Dhondiraj Sawant
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amruta Vitthal Kulkarni | R.N. Laboratories Private Limited | Company Secretary | |
| Darshan Harish Bhawsar | 10983207 | R.N. Laboratories Private Limited , Garonit Pharmaceuticals Private Limited | Director |
| Nitin Sham Lal Garg | 02430137 | R.N. Laboratories Private Limited , Garonit Pharmaceuticals Private Limited | Director |
| Rohit Shamlal Garg | 00700594 | R.N. Laboratories Private Limited , Garonit Pharmaceuticals Private Limited | Director |
| Vijay Nilkanth Koyande | 08726545 | R.N. Laboratories Private Limited , Garonit Pharmaceuticals Private Limited | Director |
| Roopkamal Grover | 10774677 | Sanhit Risk & Growth Llp | Designated Partner |
| Suman Agarwal | 10774676 | Sanhit Risk & Growth Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanket Dhondiraj Sawant
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanket Dhondiraj Sawant
Sanket Dhondiraj Sawant currently holds 3 directorships: R.N. Laboratories Private Limited (Director, since 30 Jul 2021, revenue ₹135 Cr (FY 2025)); Garonit Pharmaceuticals Private Limited (Director, since 24 Dec 2024, revenue ₹1.5 Lakh (FY 2025)); Sanhit Risk & Growth Llp (Designated Partner, since 10 Sep 2024).
Sanket Dhondiraj Sawant was first appointed on 30 Jul 2021 as Director at R.N. Laboratories Private Limited. The most recent appointment on record is 24 Dec 2024 at Neelam Garg Foundation.
The 2 current companies of Sanket Dhondiraj Sawant that report revenue have a combined latest revenue of ₹135 Cr: R.N. Laboratories Private Limited ₹135 Cr (FY 2025); Garonit Pharmaceuticals Private Limited ₹1.5 Lakh (FY 2025).
Sanket Dhondiraj Sawant held 1 earlier board appointment: Neelam Garg Foundation (Additional Director, 24 Dec 2024 to 02 May 2025).
The current boards of Sanket Dhondiraj Sawant's companies include Amruta Vitthal Kulkarni (R.N. Laboratories Private Limited), Darshan Harish Bhawsar (R.N. Laboratories Private Limited), Nitin Sham Lal Garg (R.N. Laboratories Private Limited), Rohit Shamlal Garg (R.N. Laboratories Private Limited), Vijay Nilkanth Koyande (R.N. Laboratories Private Limited), Roopkamal Grover (Sanhit Risk & Growth Llp), among others.